Professional Documents
Culture Documents
Contacts:
Email: sishu39@gmail. com
Phone: 0912925954
4. Budget ............................................................................................................................ 16
5. Schedule ........................................................................................................................ 18
6. Reference ........................................................................................................................ 18
1. Introduction
Clay is the most important, plentiful, and low cost naturally occurring material, widely used in
diverse fields that are agriculture, engineering, construction, process industries and
environmental application [1]. Clay composed primarily of fine-grained minerals, which
generally show plastic behavior at appropriate water contents and hardness upon drying or
firing [2]. Clays are studied by, and used in many disciplines for fundamental, applied research
and in industry. The multidisciplinary approach is at the border between material science and
colloidal science [3].The rapid development in the use of clays and clay minerals in the
production of enhanced materials and the need for optimization of clays for hundreds of uses,
including the area of health, is the consequence of endeavor of clay science which combining
chemistry, colloid science, material science, environmental science, physics, soil science, civil
engineering , geotechnical engineering and biological science [3, 4]. The term bentonite, which
is very frequent in the business world is used to designate any plastic, colloidal, swelling clay
dominated by one of the largest groups of clay minerals called smectite (such as
montmorillonite, nontronite, beidellite, saponite and hectorites) with no regards for its origin
[1, 5-6]. The member of clay mineral group called mica‖ is often found in bentonite as a minor
clay mineral impurity. Non-clay mineral found in bentonite are zeolites, feldspars, carbonates,
gypsum, and crystalline silica (quartz and opals) [7-9] Commercial bentonite contains either
calcium montmorillonite (Ca2+ -montmorillonite) or sodium montmorillonite (Na+ -
montmorillonite) and lower amount of other minerals [6]. Bentonite are extensively used in
foundry sand as a binder, in paper industry, drilling mud, catalysis, barrier for water and nuclear
waste, iron ore pellets, ceramics and refectories, rubber, cement, soil stabilization, cat litter,
perfume, cosmetic, plastic, paint, food and pharmaceutical [1]. In pharmaceutical industry
bentonite is commonly used as medicinal product as an excipient and active ingredient in the
forms of liquid (suspensions, emulsions), semisolid (creams, ointments) and solid (capsules,
tablets and powders) either for topical or oral administration [10-15]. The usefulness of the
bentonite due to which it is considered as a suitable pharmaceutical raw material are high
surface area, small particle size, porous nature, high swell potential, gel formation, alkaline
nature, high cation exchange capacity low or null toxicity for the patient and low price [16-19].
The worldwide raw material, bentonite, also occurs in Ethiopia (Afar, Oromia, Amhara and
other regions) in a large scale. Though bentonites found abundantly in Ethiopia but none of
them have yet been properly characterized or investigated for pharmaceutical, food, cosmetics,
water and wastewater treatment, oil bleaching application. Therefore prior to its use, it is crucial
importance for indigenous bentonite to be evaluated and/or purified, modified by different
chemical and physical treatments to comply with the requirements set forth by major
pharmacopeias to achieve the status of pharmaceutical raw material as suitability study of any
bentonite before its use in manufacturing medicinal products is unavoidable [18,21].And also
, the need to enhance its properties for other industrial application.
Keeping in view that, the basic requirements for bentonite to be used as pharmaceutical raw
material are: mineralogical, microbiological and chemical inertness. The properties such as
swelling power, gel formation, CEC, surface area and pore distribution, and particle size
analysis are also important for particular uses.
Before usage, the clay often has to be processed to increase the purity of the main phase, to
improve the properties related to pharmaceutical application and to remove grit and non-
swelling phases, such as quartz, feldspars etc. It is also important to mention that no bentonite
can be equally well in the manufacturing of different medicinal product. Moreover, their
specific function in any particular formulation depends on both their physical properties and
chemical features. For example, its use as a suspending and tablet disintegrate agent mostly
depend upon swelling and gelling properties while as a drug adsorbent and drug carrier in
control drug release system depends upon its specific surface area, porous structure and cation
exchange capacity value.
In Ethiopia bentonite are found in abundance but none of them have neither been properly
characterized nor investigated for pharmaceutical application. Therefore, the feasibility studies
on the basis of major pharmacopeia’s, oil bleaching, purification, water and wastewater
treatments are necessary and important to investigate its suitability for particular use. To
achieve this goal the knowledge of characteristics properties of bentonite related to
pharmaceutical use, oil bleaching, water and wastewater treatment, and impurities from the
characterization study of the raw material is first needed to adopt proper purification
process/chemical treatments to make it suitable for use with improved properties. As expected,
clay from all of Ethiopia sites may have different composition, properties and may require
different processing technique for its pharmaceutical, oil bleaching, water and wastewater
treatments suitability, which is a wide range subject required huge fund and cannot be done in
a single lab and human resources.
In this study, the bentonite from Afar, Amhara and Oromia regions mines sites will be collected
and studied, characterized i.e. mineralogical, geochemical, microbiological and
pharmacopeia’s suspension tests and then necessary processing technique will be developed to
purify the material for pharmaceutical use, oil bleaching, water and wastewater treatment will
be carried out. These laboratories testing will be essential to assess the potential application
before suggestion can be made for further processing to make them suitable for pharmaceutical
industry and other applications. This study will also provide the road map for processing using
local bentonite in pharmaceutical industry and other processing units. No doubt the suitability
study on local bentonite will generate an alternate income and the processing will convert the
raw material into value added product for export and local use.
1.2.Objectives
1.2.1. General Objectives
The general objective of the research is production and characterization of local bentonite for
industrial Application
Prior to the purification process, the raw samples will be characterized using XRD, XRF, ICP-
AES, SEM, Particle Size Analyzer, Surface Area Analyzer, CEC, Pharmacopeias Suspension
Tests. This is important because to know that whether the local bentonites are suitable (i.e.
fulfilling the basic requirement of pharmacopeia and having contents of crystalline silica within
the permitted amount) or they failed to comply with required specification.
After characterization and knowing the impurities in raw form further processing for
purification, conversions and activations will be adopted.
2. Literature Review
2.1. Clay and Clay Minerals
The use of clay and clay minerals in pharmaceuticals and cosmetics are very ancient. Clays
are versatile and low cost naturally occurring material, which has been used since antiquity,
characterized by a primitive economy, going through all historical eras of human civilization
to our contemporary time. In present time we can find clay in natural, modified or synthetic
form, as well as mixtures of clays with different origins and colors which may be used for
various therapeutic purposes. The clay in raw form is inexpensive and abundant material
worldwide. Though Clay is important, inexpensive and widely used industrial raw material
but still there is some confusion in the meaning of clay and clay mineral.
A rock which contains Ca2+ -montmorillonite or Na+ -montmorillonite as major clay minerals
is called calcium bentonite or sodium bentonite respectively [6]. Commercial Bentonite
contains either Ca2+ -montmorillonite or Na+ -montmorillonite and lower amount of other
minerals [6, 33].
2.3. Industrially Attractive Properties of Bentonite
Bentonite is a natural material varies in composition and texture. Hence, they are not performed
equally well for specific industry. Bentonites are mainly composed of a Montmorillonite with
minor contents of impurities that give it a unique fingerprint. The more montmorillonite in the
bentonite ore, the better it will perform as an industrial raw material [1]. The other clay, non-
clay mineral, heavy and trace element, and pathogenic microorganism that might be present in
bentonite, reduce its net drawing power. For example, the mineral kaolinite, mica, gypsum,
calcite, crystalline silica (quartz and cristobolite), the toxic element especially arsenic and lead,
the photogenic bacteria i.e. Escherichia Coli and salmonella species and other organic
compound might be present in bentonite [1,6,18] which dilutes its potential use in industries
especially in pharmaceutical sector [1,3,18,22]. Apart from its purity, bentonite ability to
industrial use comes from several properties but the most important are described below: i.
Cation Exchange Capacity The cation exchange capacity (CEC) is one of the basic properties
of clay minerals. Cations are attracted and held in between the sheets and on the edges of
particles in order to maintain the electro-neutrality of particle charges. CEC is defined as ―the
quantity of cations reversibly adsorbed by clay particles‖, expressed as milliequivalents per 100
grams (meq/100g) of dry clay [34]. The total CEC consists of two parts namely the exchange
capacity of the interlayer and that of the edges. The interlayer exchange capacity comes from
isomorphic substitutions of aluminium by magnesium at octahedral and /or silicon by
aluminium at tetrahedral leads to the net negative charge, the cations then balances this ionic
deficiency. This part is independent of pH value, so gives almost constant value. The CEC
results from the edge are strongly pH dependent. At pH 7 about 20% of the CEC of smectite is
located at the edges [35-36]. In the acid pH range, the edges are positively charged; thus, the
edges do not contribute to the measured CEC. While in the basic pH range, the edges are
negatively charged; therefore, in this pH range all edges contribute to the CEC. The CEC values
are expressed in unit recommended by IUPAC known as centimole of positive charge per
kilogram of dry clay sample (cmol(+)/kg), which is numerically equal to the traditional unit
called milliequivalents per hundred grams of clay (meq/100g). Smectite have high CEC, which
is in the range of 40-150 meq/100g. This high CEC of smectite is due to the high isomorphic
substitution occurring within the octahedral and tetrahedral layers [1]. Sodium montmorillonite
has a CEC which is generally between 80 and 130 meq/100g. On the other hand, Ca2+ -
montmorillonite has a CEC normally ranges from 40-70 meq/100g. Among the clay minerals,
the bentonites enjoy wide applications in the pharmaceutical industry because of their high
swelling and high CEC [12, 30, 37]. It is due to their high CEC that smectite can interact with
certain drugs affecting their bioavailability. Nevertheless, this interaction could be
advantageous in the formulation of controlled release systems, which is one of the most
attention-grabbing fields of clay applications at present [14,31]. The variation in
montmorillonite interlayer cations and CEC are resulting changes in drug loading ability or
adsorption capacity [38]. ii. Swelling The most important property of smectite and
corresponding bentonite is the uptake of water in the interlayer space and the resulting swelling
of the mineral. Swelling is defined as the change in physical state of clay from an anhydrous
solid to gel [39-40]. It is due to this property that bentonite can be used as a disintegrate agent
for tablets formulation, for preparation of oral and topical suspension [18, 33]. There are two
stages of swelling: one is the crystalline and the other is osmotic swelling. In former case the
smectite can take water gradually from one to four layers [34-5], controlled by balancing
between strong electrostatic and hydration repulsive forces [46, 51-54]. While in osmotic
swelling complete dissociation of the smectite layers occur [50, 55], which is generally based
on Defuse Double Layer Theory [56- 59]. The increase in basal spacing by swelling depends
on the bentonite mineralogy, types of exchangeable cation, magnitude of the layer charge and
hydration of exchangeable cations [55,60]. Usually sodium bentonite develops higher swelling
than calcium ones, therefore for specific purposes the purification and conversion techniques
are applied to improve the properties especially swelling of poor bentonite [32]. According to
Japanese pharmacopoeia [61] the required swelling property of bentonite for pharmaceutical
use is 20ml, while specified by European pharmacopeia [27] and US pharmacopeia [25] are
22 ml and 24ml respectively. iii. Surface Area and Porosity Bentonites are porous in nature.
The high contents of montmorillonite contained in the bentonite are the main source of
porosity. In a solid, the voids located among and within particles are known as pore. The pores
can be cylindrical, parallel-sided silt, cavity and ink-bottle of different sizes [60]. The IUPAC
classified the pores by their internal pore width [62]. The diameter of cylindrical pore and the
distance between opposite walls in case of silt pore can be taken as the internal width. The
pores with internal widths greater than 50 nm, between 2 nm and 50 nm and smaller than 2 nm
are called macropores, mesopores and micropores respectively [62-64]. The macropores lie
among the particle while mesopores and micropores lie within the particle [9]. These three
types of pores are often found in bentonite. The physicochemical properties of bentonite
especially adsorption depends extensively on mesopores and micropores [9]. The pores area of
the inner and outer walls in one gram of solid is defined as specific surface area [65]. Surface
area approximately corresponds to the walls of micropores and mesopores. The contribution of
the macropore surface to the total surface area is negligible [65]. The pores volume in one gram
of solid is taken as specific pore volume. A number of methods have been investigated to
determine pore-size distribution, surface area and pore volume. They include mercury
porosimetry, N2 adsorption-desorption and thermoporometry [62, 66].
4. Budget
Table 1: Budget
N Activities
May
May
Nov
Aug
Nov
Aug
Nov
Mar
Mar
Dec
Dec
Apr
Apr
Feb
Sep
Feb
Sep
o
Oct
Oct
Oct
Jun
Jun
Jan
Jan
Jul
Jul
1 Literature survey
2 Data collection
3 Data analysis and
Experimental
work
4 Progress report
compilation
5 Draft report
submission
6 Final report
compiling and
binding
7 Final report
submission
6. Reference
[1]. Murray, H.H. Applied clay Mineralogy: Occurrences Processing and Application of
Kaolins, Bentonites, Palygorskite-Sepiolite, and common clay, Development in Clay
Science; Elsevier; Amsterdam, 2007.
[2]. Guggenheim, S.; Martin, R.T. Definition of clay and clay minerals: joint report of
AIPEA nomenclature and CMS nomenclature committees. Clays and Clay Minerals. 995
43, 255-256.
[3]. Bergaya, F.; Theng, B.K.G.; Lagaly, G.; Handbook of Clay Science; Elsevier
Publication; Amsterdam, 2006.
[4]. Laird, D. News from the 48th annual meeting of the clay minerals society. The Clay
Minerals Society, September 25-31, 2011.
[5]. Grim, R.E. Clay Mineralogy; McGraw- Hill; New York, 1968.
[6]. Grim, R.E.; Guven, N. Bentonites- Geology, Mineralogy, properties and Uses,
Developments in sedmentology; Elsevier; New York, 1978.
[7]. Moore,D.M.; Reynolds, R.C. X-ray Diffraction and the Identification and Analysis of
Clay Minerals; Oxford University Press; Oxford, 1997. [8]. Christidis, G.E.; Scott, P.W.;
Dunham, B.C. Acid activation and bleaching capacity of bentonites from theis lands of
Milosand Chios, Aegean, Greece. Applied Clay Science,1997, 12,329-347.
[9]. Onal, M.; Sarıkaya, Y.; Alemdaroglu, T.; Bozdogan, I. The effect of acid activation
some of the physicochemical properties of a bentonite. Turkish Journal of Chemistry. 2002,
26, 409–416.
[10]. Ferrand, T.; & Yvon, J. Thermal properties of clay pastes for pelotherapy. Applied
Clay Science, 199, 6, 21-38.
[11]. Kibbe, A.H. Handbook of Pharmaceutical Excipients, American pharmaceutical
Association, Washington, DC, 2000.
[12]. Carretero, M.I. Clay minerals and their beneficial effects upon human health. A
review. Applied Clay Science. 2002, 21, 155-163.
[13]. Poensin, D.; Carpentier, P.H.; Fechoz, C.; Gasparini, S. Effects of mud pack treatment
on skin microcirculation. Joint Bone Spine. 2003,70, 367-370.
[14]. Lopez- Galindo, A.; Viseras, C. Pharmaceutical and cosmetic application of clays,
In. Clay Surfaces, Fundamentals and Applications; Elsevier; Amsterdam, 2004, pp 267-
289.
[15]. Viseras, C.; Aguzzi, C.; Cerezo, P.; Lopez- Galindo, A. Uses of clay minerals in
semisolid health care and therapeutic products. Applied Clay Science. 2007, 36, 37-50.
[16]. Cara, S.; Carcangiu, G.; Padalino, G.; Palomba, M. & Tamanini, M. The bentonites
in pelotherapy: thermal properties of clay pastes from Sardinia (Italy). Applied Clay
Science. 2000, 16, 125–132.
[17]. Carretero, M.I.; Gomes, C.S.F.; Tateo, F. Clays and Human Health. In Handbook of
clay science; Bergaya, F., Theng, B.K.G., Lagaly, G., Ed.; Elsevier: Amsterdam, 2006; pp
717- 741.
[18]. Lopez-Galindo, A.; Viseras, C. & Cerezo, P. Compositional, technical and safety
specifications of clays to be used as pharmaceutical and cosmetic products. Applied Clay
Science. 2007, 36, 51–63.
[19]. Veniale, F.; Bettero. Jobstraibizer, A.; Setti, M. Thermal muds: perspectives of
innovations. Applied Clay Science. 2007, 36, 141–147.
[20]. Brown, T.G.; Bide, T.; Hannis, S.D.; Idoine, N.E.; Hetherington, L.E.; Shaw, R.A.;
Walters, A.S.; Lusty, P.A.J.; Kendall, R. World Mineral Production2004- 2008; British
Geological survey, 2010; p 13. [21]. Viseras, C.; Lopez-Galindo, A. Pharmaceutical
applications of some Spanish clays (sepiolite, palygorskite, bentonite): some
preformulation studies. Applied Clay Science. 1999, 14 (1-3), 69-82.
[22]. Viseras, C.; Cultrone, G.; Cerozo, P.; Aguzzi, C.; Baschini, M.T.; Valles, J.; Lopez-
Galindo, A. Characterization of northern Patagonian Bentonites for pharmaceutical Uses.
Applied Clay Science. 2006, 31, 272-281.
[25]. USPC. Bentonite. in. US Pharmacopoeia 30 and National Formulary 25; US
Pharmacopoeial Convention; Rockville, MD, USA, 2007; p 1066.
[27]. EPC. Bentonite, In European Pharmacopoei, 5th Ed.; European Pharmacopoeia
Convention; Strasbourg, France, 2005; p 1068.
[29]. Carretero, M. I.; Manuel, P. Clay and non-clay minerals in the pharmaceutical
industry Part I. Excipients and medical applications. Applied Clay Science, 2009, 46, 73–
80.
[30]. Carretero, M. I.; Manuel, P. Clay and non-clay minerals in the pharmaceutical and
cosmetic industries Part II. Active ingredients. Applied Clay Science. 2010, 47, 171–181.
[31]. Viseras, C.; Cerezo, P.; Sanchez, R.; Salcedo, I. & Aguzzi C. Current challenges in
clay minerals for drug delivery. Applied Clay Science, 2010, 48, 291-295.
[32]. Odom, I.E. Smectite Clay Minerals: Properties and uses; Philosophical Transactions
of the Royal Society; London. 1984; 391-409.
[33]. O‘ Driscoll, M. Bentonite, overcapacity in need of markete, Industrial Mineral. 1988,
250, 43-67.
[34]. Onal, M. Swelling and cation exchange capacity relationship for the samples obtained
from a bentonite by acid activations and heat treatments. Applied Clay Science 2007 37,
74–80.
[35]. Lagaly, G. Characterization of clays by organic Compounds.Clay minerals.1981, 16,
1-21.
[36]. Lagaly, G. In redients of flow of kaolin and bentonite dispersions. Applied Clay
Science.1989, 4,105-123.
[37]. Lin, F.H.; Lee, Y.H.; Jian, C.H.; Wong, J.M.; Shieh, M.J.; Wang, C.Y. A study of
purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials
.2002, 23, 1981-1987.
[38]. Aguzzi, C.; Viseras, C.; Cerezo, P.; Rossi, S.; Ferrari, F.; López- Galindo A. &
Caramella C. Influence of dispersion conditions of two pharmaceutical grade clays on their
interaction with some tetracyclines. Applied Clay Science. 2005, 30, 79–86.
[39]. Komine, H. Ogata, N. Experimental study of swelling characteristics of compacted
bentonite. Canadian Geotechnical Journal. 1994, 31, 478-490.
[40]. Komine, H.; Ogata, N. Prediction of swelling characteristics of compacted bentonite.
Canadian Geotechnical Journal. 1996, 33, 11-12.
[41]. Wai, K.N.; Dekay, H.G.; Banker G.S. Applications of the montmorillonites in tablet
making. Journal of Pharmaceutical Sciences. 1966, 55, 1244–1248.
[57]. Fielden, K.E. Water-dispersible tablets. 1996, US patent No- 5556639.
[42]. Viseras, C.; Ferrari, F.; Yebra, A.; Rossi, S.; Caramella, C.; López- Galindo, A.
Disintegrant efficiency of special phyllosilicates: smectite, palygorskite, sepiolite. STP
Pharma Sciences, 2001, 11, 137–143.
[43]. Norrish, K. The swelling of montmorillonite. Faraday Discussions of the Chemical
Society. 1954, 18,120-134.
[44]. Madsen, F. T. & Moller-Vonmoos, M. The swelling behaviour of clays. Applied Clay
Science. 1989, 4, 143-156.
[45]. Viani, B.; Low, P.F.; Roth, C.B. Direct measurement of the relation between
interlayerforce and interlayer distance in the swelling of montmorillonites. Journal of
Colloid and Interface Science. 1983, 96, 229-244.
[46]. Young, R.N.; Mohamed, A.M.O. Canadian Geotechnical Journal., 1992, 29, 1060-
1070.
[47]. Sato, T.; Watanabe, T.; Otuska, R. Effects of layer charge, charge location, and energy
change on expansion properties of dioctahedral smectites. Clays and Clay Minererals.
1992, 40, 103-113.
[48]. Laird, D.A. Influence of layer charge on swelling of smectites. Applied Clay Science
. 2006, 34, 74-87.
[49]. McEwan, D. M. C.; Wilson, M. J. Interlayer and intercalation complexes of clay
minerals, in Crystal structures of clay minerals and their X-ray identification. Mineralogical
Society; London, 1984; pp 197-248.
[50]. Hamwall, J.B.; Low, P.F. The hydrostatic repulsive force in clay swelling. Soil
Science. 1956, 82, 135-145.
[51]. Callaghan, J. C.; Ottevill, R.H. Inter particles forces in montmorillonite gels Faraday
Discussions of the Chemical Society. 1974, 57, 110-118.
[52]. Secor, R.B.; Radke, C.J. Spillover of the diffuse double layer on montmorillonite
particles. Journal of Colloid and Interface Science. 1985, 103, 237-244.
[53]. Kjellander, R.; Marcelja, S.; Quirk. J.P. Attractive double-layer interactions between
calcium clay particles. Journal of Colloid and Interface Science. 1988, 126, 194-211.
[54]. Onal, M. Physicochemical properties of bentonites: an overview. Commun. Fac. Sci.
Univ. Ank. Series.2006, 52 (2), 7-21.
[55]. Japanese Pharmacopeia Commission (Ed), Japanese pharmacopeia, 15th Ed; Japan,
2006; p. 341.
[56]. Gregg, S. J.; Sing, K.S.W. Adsorption, Surface Area and Porosity; Academic Press;
New York, 1982.
[57]. Sing, K. S. W. ; Everett, D. H.; Haul , R. A. W.; Moscou, L.; Pierotti, R. A.;
Rouquerol, J.; Siemieniewska, T. Reporting physisorption data for gas/solid 139 systems
with special reference to the determination of surface area and porosity. Pure and Applied
Chemistry. 1985, 57(4), 603-619.
[58]. Fisher, C.; Gaupp, R. Multi-scale rock surface area quantification- a systematic
method to evaluate the reactive surface area of rocks. Chemie der Erde – Geochemistry.
2004, 64, 241-256.
[59]. Noyana, Hulya.; Onal, M.; Sarıkaya, Yuksel.; The effect of sulphuric acid activation
on the crystallinity, surface area, porosity, surface acidity, and bleaching power of a
bentonite. Food Chemistry. 2007, 105, 156–163.
[60]. Sarikaya, Y.; Ceylan, H.; Bozdogan, I.; Akinc, M. Determination of pore size
distribution from thermal data analysis–thermoporometry. Turkish Journal of Chemistry.
1993, 17,119 - 124.
[61]. Murray, H.H. Mineralogy and geology of the Maungaparerua halloysite deposit in
New Zealand. Clays and Clay Minerals. 1977, 25, 1–5.
[62]. Elzea, J.; Murray, H.H. Variation in the mineralogical, chemical, and physical
properties of the Cretaceous clay spur bentonite in Wyoming and Montana. Applied Clay
Science .1990, 5, 229–248.
[63]. Luckham, P.F.; and Rossi, S. The colloidal and rheological properties of Bentonite
suspensions. Advance in Colloid and Interface Science. 1999, 82, 43- 92.
[64]. Yildiz, N.; Calimli, A. & Sarikaya, Y. The characterization of Na2CO3 activated
kutahya bentonite. Turkish Journal of Chemistry. 1999, 23, 309-317.
[65]. vista, R.L. Clays: Annual Report 1990, US Bureau of Mine. 1992.
[66]. Harvey, C.C & Lagaly, G. Conventional Applications. In Handbook of clay science;
Bergaya, F., Theng, B.K.G., Lagaly, G., Ed.; Elsevier: Amsterdam, 2006, pp 501-540.
[67]. Allo, W.; Murray, H.H. Mineralogy, chemistry and potential applications of a white
bentonite in San Juan Province, Argentina. Applied Clay Science. 2004, 25, 237–243.
[68]. Keith, K.S.; Murray, H.H. Clay liners and barriers. In Industrial Minerals and Rocks,
6th Edition; Carr, D. D.; ed.; Society for Mining, Metallurgy and Exploration, Littleton,
CO. 1994, pp. 435–462.
[69]. Griffith, J. Acid activated bleaching clays. Ind. Miner. Mag., September, 1990, 55–
67.
[70]. Sarmento, M.R.; Oliveira, J.C.; Boulton, R.B. Selection of low swelling materials for
protein adsorption from white wines. International Journal of Food Science and
Technology. 2000, 35, 41–47.
[71]. Mielenz, R.C. and King, M.E. Physical–chemical properties and engineering
performance of clays. Calif. Div. Mine. Bull., 1955, 169, 196–254.
[72]. White, W.A. The Properties of Clays. MS Thesis, University of Illinois, IL, 1947.
[73]. Rateau, J.G.; Morgant, G.; Droy-Priot parier,M.T.; Parier, J.L. Current Med Res
Opinion, 1982, 8, 233-241.
[74]. Dupont, C.; Moreno, J.L.; Barau, E.; Bargaoui, K.; Thian, E.; Plique, O. Effect of
diosmectite on intestinal permeability changes in acute diarrhea: a double blind
placebocontrolled trial. Journal of Pediatric Gastroenterology and Nutrition. 1992 14, 413–
419.
[75]. Madkour, A.A.; Madina, E.M.; El-Azzouni, O.E.; Amer, M.A., Amer, T.M.; El
Walili-Abbass, T. Smectite in acute diarrhea in children: a double-blind study placebo-
controlled clinical trial. Journal of Pediatric Gastroenterology and Nutrition. 1993, 17, 176.
[76]. Mahraoui, L.; Heyman, M.; Plique, O.; Droy-Lefaix Desjeux, M.T.; Desjeux J.F.
Apical effect of diosmectite on damage to the intestinal barrier induced by basal tumor
necrosis factor. Gut. 1997, 40, 339-343.
[77]. Guarino, A., Bisceglia, M., Castellucci, G., Iacono, G., Casali, L.G., Bruzzese
Musetta, E. & Greco L.. Smectite in the treatment of acute diarrhea: a nation wider and
omized controlled study of the Italian Society of Pediatric Gastroenterology and
Hepatology (SIGEP) in collaboration with primary care Pediatricians. Journal of Pediatric
Gastroenterology and Nutrition. 2001, 32, 1, 71-75.
[78]. Jones,B.F.; Galan, E. Sepiolite and palygorskite. In: hydrous Phyllosilicates. Reviews
in Mineralogy vol. 19. Bailey, S.W. ed.; Mineralogical Society of America: Washington,
D.C. 1988, pp 631-674.
[79]. Vicente Rodríguez, M.A.; Lopez Gonzalez, J.D.; Bañares Muñoz, M.A.; Married
Linarejos, J. Acid activation of a Spanish sepiolite: II. Consideration of kinetics and
Modifications physicochemical generated. Clay Minerals. 1995, 30, 315-323.
[80]. Joekes,A.M.; Rose, G.A.; Sutor, J. Multiple renal silica calculi. British Medical
Journal. 1973, 1, 146-147.
[81]. Levison, D.A.; Crocker, P.R.Banim, S.; Wallace, D.M.A. Silica stones in the urinary
bladder. Lancet .1982, 27, 704-705.
[82]. Bickel, M. Kauffmann, J.R. Gastric gel mucus thickness: effect of distention 16, 16-
dimethyl prostaglandin E2, and carbenoxolone. Gastroenterology. 1981, 80, 770-775. 144
[83]. Allen, A. Pre-epithelial factors in resistance to acid and pepsin. European Journal of
Gastroenterology and Hepatology.1990, 2, 168-171.
[84]. Pearson, J.P.; Ward, R.;Allen, A.; Roberts, N.B.;Taylor, W. Gut,1986, 27, 243.
[85]. Droy-Lefaix, M.T. Intestinal mucosa barrier and smectite. Revue de Medecine
Veterinaire. 1987, 138, 5, 411-421.
[86]. Ditter, B.; Urbaschek, R.; Urbaschek, B. Ability of various adsorbents to bind
endotoxins in vitro and to prevent orally induced endotoxemia in mice. Gastroenterology.
1983, 84, 6, 1547-1552.
[87]. Gardiner, K.R.; Anderson, N.H.; McCaigue, M. D.; Erwin, P. J.; Halliday Rowlands,
B.J. Adsorbents as antiendotoxin agents in experimental colitis. Gut, 1993, 34 (1), 51-55.
[88]. Droy-Lefaix, M.T.; Tateo, F. Clays andclayminerals in the drugs. In Handbook of
clay science; Bergaya, F., Theng, B.K.G., Lagaly, G.; Ed.; Elsevier: Amsterdam, 2006; pp
743-752.
[89]. Braun, D.B. Over the Counter Pharmaceutical Formulations; Noyes Publications;
New Jersey, 1994; p 318.
[90]. Kamp, H.F. U.S. Patent,4748978,1988.
[91]. Feinstein, W.; Bartilucci, A.T. Comparative Study of Selected Disintegrating Agents.
Journal of Pharmaceutical Sciences.1966, 55,332-334.
[92]. Gross, H.M.; Becker, C.H. A comparative study of disintegrating agent. Journal of
American Pharmaceutical Associations Science. 1952, 41, 157-161.
[93]. Firouzabadian, A.; Huyck, C.L. Some recently developments chemicals as
disintegrating agents for compressed tablets. Journal of American Pharmaceutical
Associations Science. 1954, 43, 248-250.
[94]. Nair, A.D.; Bathia, V.N. Studies on Disintegration of Compressed Tablets. Effecton
Disintegration of the Procedure Used in the Incorporating Disintegrating Agent. Journal of
American Pharmaceutical Associations Science.1957, 46, 131- 134.
[95]. Viseras, C.; Meeten, G.H.; LópezGalindo, A. Pharmaceutical grade phyllosilicate
dispersions: The Influence of shear history on floc structure. International Journal of
Pharmaceutics.1999, 182,7-20.
[96]. Ma, K.; Pierre, A.C. Colloidal behaviour of montmorillonite in the presence of Fe3+
ions. Colloids and Surfaces A. 1999, 155-359.
[97]. Abend, S.; Lagaly, G. Sol-gel transitions of sodium montmorillonite dispersions.
Applied Clay Science. 2000, 6, 201-227.
[98]. Van-Olphen, H. An Introduction to Clay Colloid Chemistry; John Wiley; New York,
1977, p 318.
[99]. Permien, Y.; Lagaly, G. The rheological and colloidal properties of bentonite
dispersions in the presence of organic compounds. V. Bentonite and sodium
montmorillonite and surfactants. Clays and Clay Minerals, 1995, 43, 229-236.
[100]. Aguzzi, C.; Cerezo, P.; Viseras, C. & Caramella, C. Use of clays as drug delivery
system: Possibilities and limitations. Applied Clay Science. 2007, 36, 22–36.
[101]. McGinity, J.W.; Lach, J.L. Sustained-release applications of montmorillonite
Interaction with amphetamine sulfate. Journal of Pharmaceutical Science. 1977, 66, 63-66.
[102]. Shrivestava, R.; Jain, S.; Frank, S. Dissolution dialysis stu-dies of metronidazole
montmorillonite adsorbents. Journal of Pharmaceutical Science.1985, 74, 214.
[103]. Camazano, M. S.; Sanchez, M.J.; Vicente, M.T; Dominguez-Gil, A. Adsorption of
Chlorpheniramine Maleate by Montmorillonite. International Journal of
Pharmaceutics.1980, 6, 243-251.
[104]. Fernández-Pérez, M.; Villafranca-Sánchez, M.; González-Pradas, E.; Flores
Céspedes, F. Controlled Release of Diuron from an Alginate-Bentonite Formulation: Water
Release Kinetics and Soil Mobility Study. Journal of Agriculture and Food Chemistry.
1999, 47, 791-798.
[105]. Fernández-Pérez, M.; González-Pradas, E.; Villafranca-Sánchez, M.; Flores
Céspedes, F. Ureña-Amate, M. D. Bentonite and humic acid as modifying agents in
controlled release formulations of diuron and atrazine. Journal of Environmental Quality.
2000, 29, 304-3010.
[106]. Villafranca-Sánchez, M.; González-Pradas, E.; Fernández-Pérez, M.; Martínez
López, F.; Flores-Céspedes, F.; Ureña-Amate, M.D. Controlled release of isoproturon from
an alginate-bentonite formulation: water release kinetics and soil mobility. Pest
Management Science. 2000, 56: 749-756.
[107]. Yildiz N.; Calimli A. Alteration of Three Turkish Bentonites by Treatment with
Na2CO3 and H2SO4. Turkish Journal of Chemistry. 2002, 26, 393-401.
[108]. Tateo, F.; Summa, V.; Bonelli, C.G.; Bentivenga, G. Mineralogy and geochemistry
of herbalist‘s clays for internal use: Simulation of the digestive process. Applied Clay
Science. 2001, 20, 97-109.
[109]. Mascolo, N.; Summa, V.; Tateo, F. Characterization of toxic elements in clays for
human healing use. Applied Clay Science. 1999, 15, 491-500.
[110]. Mascolo, N., Summa, V, & Tateo F. (2004). In vivo experimental data on the
mobility of hazardous chemicals elements from clays. Applied Clay Science, 25, 23-28.
[111]. Saleemi A.A.; Ahmed Z. Mineral and chemical composition of Karak Mud Stone,
Kohat Plateau, Pakistan:implications for smectite–illitization and provenance. Sedimentary
Geology. 2000,130, 229-247. #
[112]. Scarlett, B.; Cowlam, S.K. Concenteration effects in particle size analysis by
sedimentation. Proceeding of Conference on particle size analysis, Salford, Heyden,
London, 1977, 430-440.
[113]. Yildiz N.; Calimli A. Alteration of Three Turkish Bentonites by Treatment with
Na2CO3 and H2SO4. Turkish Journal of Chemistry. 2002, 26, 393-401.